Application of botulinum toxin A in chronic intrinsic rhinitis;Zastosowanie toksyny botulinowej typu A w przewlekłych nieinfekcyjnych nieżytach nosa

Otolaryngologia Polska

Volumn 65, Issue 2, 2011, Pages 103-105

  Nowak, Katarzyna ^a   Szyfter, Witold ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

alergic rhinitis; botulinum toxin; chronic rhinitis; intrinsic rhinitis

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CHRONIC INTRINSIC RHINITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; RHINITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADULT; AGED; BOTULINUM TOXINS, TYPE A; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RHINITIS; TREATMENT OUTCOME;

EID: 79959480957     PISSN: 00306657     EISSN: 00306657     Source Type: Journal    
DOI: 10.1016/S0030-6657(11)70637-0     Document Type: Article

References (15)

1. Damm M. Idiopatic rhinitis. Laryngootorhinootologie 2006; 85:361-377.
2. Sapci T, Yazici S, Evcimik MF, Bozkurt Z, Karavus A, Ugurlu B, Ozkurt E. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia. Rhinology 2008; 46:45-51.
3. Rohrbach S, Junghans K, Koehler S, Laskawi R. Minimally invasie application of botulinum toxin A in patients with idiopathic rhiitis. Head & Face Medicine 2009:1-7.
4. Liberman P. Treatment update: nonallergic rhinits Alergy Asthma Proc 2001; 22:199-202.
5. Laskawi R.The use of botulinum toxin in head and face medicine: an interdisciplinary field. Head Face Med 2008; 10:4-5.
6. Kim KS, Kim SS, Yoon JH, Han JW.The effect of botulinum toxin type A injection for intrinsic rhinitis. J Laryngol Otol 1998; 112:248-251.
7. Gordon N. The role of botulinum toxin type A in treatment-with special reference to children.Brain Dev 1999; 21:147-151.
8. Laskawi R., Ellies M. The role of botolinum toxin in the management of head and neck cancer patiens. Curr Opin Otolaryngol Head Neck Surg 2007; 15:112-116. (Pubitemid 46594864)
9. Jost WH. Other indications of botulinum toxin therapy. Eur J Neurol 200613: 65-69.
10. Ozcan C,Vayisoglu Y, Dogu O, Gurur K. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis. Am J Otolaryngol 200627:314-318.
11. Rohrbach S, Laskawi R. Botulinum toxin in otolaryngology. HNO 2004; 52:635-641.
12. Shaari CM, Sanders I, Wu BL, Biller HF. Rhinorrhea is decreased in dogs after nasal application of botulinum toxin. Otolaryngol Head Neck Surg 1995; 112:566-571.
13. Thant ZS, Tan EK. Emerging therapeutic applications of botulinum toxin. Med Sci Monit 2003; 9:40-48.
14. Bushara KO. Botulinum toxin and rhinorrhea. Otolaryngol Head Neck Surg 1996; 114:507. (Pubitemid 26097150)
15. Unal M m Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double blind, placebo controlled clinical trial. Acta Otolaryngol 2003; 123:1060-1063.